{"nctId":"NCT02933060","briefTitle":"Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache","startDateStruct":{"date":"2017-01"},"conditions":["Migraine Headache"],"count":50,"armGroups":[{"label":"IV fluid bolus","type":"EXPERIMENTAL","interventionNames":["Other: Normal saline (1000 mL)"]},{"label":"Control","type":"SHAM_COMPARATOR","interventionNames":["Other: Control"]}],"interventions":[{"name":"Normal saline (1000 mL)","otherNames":[]},{"name":"Control","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 18 or older\n* Fluent in English\n* Meets International Classification of Headache Disorders (3rd ed) criteria for migraine headache:\n\nA. At least five attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated)\n\nC. Headache has at least two of the following four characteristics:\n\nunilateral location pulsating quality moderate or severe pain intensity aggravation by or causing avoidance of routine physical activity (e.g. walking or climbing stairs)\n\nD. During headache at least one of the following:\n\n1. nausea and/or vomiting\n2. photophobia and phonophobia E. Not better accounted for by another ICHD-3 diagnosis.\n\nExclusion Criteria:\n\n* Intravenous Fluids are contraindicated in the opinion of the emergency department physician caring for the patient (ex patient has an exacerbation of congestive heart failure).\n* Intravenous fluids are required in the opinion of the emergency department physician caring for the patient (ex patient has intractable vomiting, patient has severe dehydration).\n* Have already received greater than or equal to 500 ml of intravenous fluid during this emergency department visit, prior to enrollment.\n* Currently pregnant","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Verbal Pain Score at 60 Minutes","description":"The primary outcome will be the difference in verbal pain rating (0 = no pain, 10 = maximum pain) between the start of the study intervention and one hour later, at completion of the intervention. The minimum clinically significant difference between treatment groups on the 0-10 verbal scale is 1.3.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":null},{"groupId":"OG001","value":"4.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Verbal Pain Score at 120 Minutes","description":"The difference in verbal pain rating (0 = no pain, 10 = maximum pain) between the start of the study intervention and 2 hours later. The minimum clinically significant difference between treatment groups on the 0-10 verbal scale is 1.3.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":null},{"groupId":"OG001","value":"5.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Patients Free of Pain at 2 Hours","description":"Percentage of patients in each group who are pain-free two hours after initiation of the study intervention.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null},{"groupId":"OG001","value":"32","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Patients With no or Mild Functional Disability Due to Headache at 60 Minutes","description":"Percentage of patients with functional disability due to headache rated as none or mild (able to perform all activities of daily living, but with some difficulty) at 60 minutes","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72","spread":null},{"groupId":"OG001","value":"75","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Patients Who Would Want the Same IV Fluid Treatment on a Future Visit","description":"Percentage of participants answering \"yes\" to the question: \"The next time you visit the ED with a headache, would you wish to receive the same IV fluid treatment again?\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"79","spread":null},{"groupId":"OG001","value":"67","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Patients Who Needed Rescue Medications","description":"Need for additional medications for pain control as determined by the treating physician.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"32","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Stay","description":"Length of emergency department stay","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"309","spread":"68"},{"groupId":"OG001","value":"316","spread":"93"}]}]}]},{"type":"SECONDARY","title":"Verbal Pain Score at 48 Hours","description":"Current pain as reported by participants at 48 hour follow-up (0-10 verbal scale; 0 = No Pain, 10 = Maximum Pain).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"3.3"},{"groupId":"OG001","value":"1.9","spread":"2.5"}]}]}]},{"type":"SECONDARY","title":"Percentage of Patients Reporting no Nausea or Mild Nausea at 60 Minutes","description":"Patients reporting no nausea or mild nausea","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null},{"groupId":"OG001","value":"96","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Verbal Report of Insertion Site Pain Score at 60 Minutes","description":"Pain at IV insertion site (0 = No Pain, 10 = Maximum Pain)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.42","spread":"0.97"},{"groupId":"OG001","value":"0.73","spread":"1.32"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":[]}}}